NS · Pharmaceuticals

Syncom Formulations (India) Ltd (SYNCOMF)

Pharmaceuticals & Biotechnology

Syncom Formulations (India) Ltd (SYNCOMF) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $13.07B, P/E ratio is 17.16, net margin is 11.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SYNCOMF

Market cap

$13.07B

P/E ratio

17.16

Net margin

11.2%

Syncom Formulations (India) Ltd (SYNCOMF) — FAQ

What is Syncom Formulations (India) Ltd's market cap?

Syncom Formulations (India) Ltd (SYNCOMF) has a reported market cap of $13.07B (data as of 2026-07-10).

What is SYNCOMF's P/E ratio?

The price-to-earnings (P/E) ratio for Syncom Formulations (India) Ltd (SYNCOMF) is 17.16 (data as of 2026-07-10).

Does Syncom Formulations (India) Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Syncom Formulations (India) Ltd (SYNCOMF). Check the MyAverix Finance app for the latest dividend data.

What sector is Syncom Formulations (India) Ltd in?

Syncom Formulations (India) Ltd (SYNCOMF) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is SYNCOMF listed on?

SYNCOMF is listed on NS.

What is Syncom Formulations (India) Ltd's net margin?

Syncom Formulations (India) Ltd (SYNCOMF) reports a net margin of 11.2% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)